- Milestone triggered by dosing of first patient in frontline AML Phase 3 clinical program-
Kura Oncology Receives $30 Million Development Milestone Payment in Ziftomenib AML Program with Kyowa Kirin
Seeking Alpha / 8 hours ago 2 Views
Seeking Alpha / 8 hours ago 2 Views
- Milestone triggered by dosing of first patient in frontline AML Phase 3 clinical program-
Comments